TBIO — Telesis Bio Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.07m
- $1.97m
- $27.51m
Brief: Telesis Bio Plans To Delist Its Securities From The Nasdaq Stock Market
Brief: Telesis Bio Says Co Entered Share Purchase Agreement With Yuan Yang To Sell All Of Outstanding Capital Stock Of Eton Bio
Telesis Bio Inc reports results for the quarter ended in June - Earnings Summary
Telesis Bio Inc expected to post a loss of $4.03 a share - Earnings Preview
Brief: Telesis Bio Inc - On June 6 Received Nasdaq Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard Transfer Of Listing
Telesis Bio Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Telesis Bio Inc Board Approved Expansion Of Board From Seven To Eight Members On April 16
Telesis Bio Inc reports results for the quarter ended in December - Earnings Summary
Telesis Bio Inc expected to post a loss of 22 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-iRobot Corp, Fisker Inc, International Seaways Inc
Brief: Telesis Bio Q3 EPS USD -0.37
Brief: Telesis Bio Announces Commercial Release Of Library Prep Kit For Whole Genome Sequencing
Brief: Telesis Bio Appoints William J. Kullback Chief Financial Officer
Brief: Telesis Bio Appoints William J. Kullback Chief Financial Officer
Brief: Telesis Bio Inc Says On August 28, 2023, The Company Appointed William Kullback, Age 63, As Chief Financial Officer
Brief: Telesis Bio Q2 revenue USD 8.7 million
Brief: Telesis Bio Inc Files For Shelf Of Up To 30.04 Million Shares Of Common Stock By Selling Stockholders
Brief: Telesis Bio Board Was Increase To Eight Directors
Brief: Telesis Bio Announces Closing Of $28 Mln Private Placement Of Preferred Stock